Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2

Haematologica. 2018 Aug;103(8):e348-e350. doi: 10.3324/haematol.2017.187302. Epub 2018 Mar 22.

Authors

Constance Baer¹, Verena Muehlbacher², Wolfgang Kern², Claudia Haferlach², Torsten Haferlach²

Affiliations

¹ MLL Munich Leukemia Laboratory, Germany constance.baer@mll.com.
² MLL Munich Leukemia Laboratory, Germany.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Core Binding Factor Alpha 2 Subunit / genetics
Eosinophilia / complications*
Female
Gene Rearrangement / genetics*
Humans
Leukemia, Lymphoid / complications
Leukemia, Lymphoid / genetics
Leukemia, Myeloid / complications
Leukemia, Myeloid / genetics
Male
Middle Aged
Mutation
Neoplasms / complications
Neoplasms / genetics*
Oncogene Proteins, Fusion / genetics
Receptor, Fibroblast Growth Factor, Type 1 / genetics
Receptor, Platelet-Derived Growth Factor alpha / genetics
Receptor, Platelet-Derived Growth Factor beta / genetics
Young Adult

Substances

Core Binding Factor Alpha 2 Subunit
Oncogene Proteins, Fusion
PCM1-JAK2 fusion protein, human
RUNX1 protein, human
FGFR1 protein, human
PDGFRB protein, human
Receptor, Fibroblast Growth Factor, Type 1
Receptor, Platelet-Derived Growth Factor alpha
Receptor, Platelet-Derived Growth Factor beta